Pfizer and Genentech Duke it Out in Court over Herceptin Biosimilar Patents Post author:Sam Post published:November 21, 2017 Post category:BioPharma Genentech is claiming that Pfizer’s proposed biosimilar infringes 40 of its patents. Source: BioSpace You Might Also Like Abiomed Fourth Quarter Fiscal 2017 Earnings And Conference Call Notification April 12, 2017 Cambridge's Dimension Therapeutics Tanks to a New Low After Revealing Interim Hemophilia B Data January 31, 2017 Meet the 4 VC-Backed Biotech Startups That Just Landed Space in Kendall Square September 5, 2017
Cambridge's Dimension Therapeutics Tanks to a New Low After Revealing Interim Hemophilia B Data January 31, 2017
